XML 44 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (USD $)
3 Months Ended
Oct. 31, 2012
Oct. 31, 2011
Cash flows from operating activities:    
Net income $ 7,435,000 $ 12,601,000
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization of property, plant and equipment 2,025,000 2,420,000
Amortization of intangible assets with finite lives 1,582,000 1,719,000
Amortization of stock-based compensation 745,000 873,000
Deferred financing costs 352,000 366,000
Change in fair value of contingent earn-out liability (2,378,000) 0
Loss on disposal of property, plant and equipment 9,000 0
Provision for (benefit from) allowance for doubtful accounts 211,000 (55,000)
Provision for excess and obsolete inventory 671,000 565,000
Excess income tax benefit from stock-based award exercises 0 (19,000)
Deferred income tax expense (benefit) 1,058,000 (476,000)
Changes in assets and liabilities:    
Accounts receivable 9,104,000 (3,616,000)
Inventories 3,042,000 (3,380,000)
Prepaid expenses and other current assets 198,000 407,000
Other assets (40,000) (18,000)
Accounts payable (6,757,000) (4,870,000)
Accrued expenses and other current liabilities (7,273,000) (6,466,000)
Customer advances and deposits (2,586,000) (2,074,000)
Other liabilities 518,000 225,000
Interest payable 1,500,000 1,500,000
Income taxes payable 2,462,000 (474,000)
Net cash provided by (used in) operating activities 11,878,000 (772,000)
Cash flows from investing activities:    
Purchases of property, plant and equipment (1,063,000) (1,443,000)
Net cash used in investing activities (1,063,000) (1,443,000)
Cash flows from financing activities:    
Repurchases of common stock 0 (78,651,000)
Cash dividends paid (4,773,000) (6,100,000)
Proceeds from exercises of stock options 323,000 2,241,000
Proceeds from issuance of employee stock purchase plan shares 248,000 287,000
Excess income tax benefit from stock-based award exercises 0 19,000
Payment of contingent consideration related to business acquisition (1,000) (63,000)
Net cash used in financing activities (4,203,000) (82,267,000)
Net increase (decrease) in cash and cash equivalents 6,612,000 (84,482,000)
Cash and cash equivalents at beginning of period 367,894,000 558,804,000
Cash and cash equivalents at end of period 374,506,000 474,322,000
Cash paid during the period for:    
Interest 87,000 95,000
Income taxes 570,000 2,459,000
Non cash investing and financing activities:    
Cash dividends declared 4,784,000 6,102,000
Accrued repurchases of common stock $ 0 $ 4,502,000